Beacon Therapeutics
Khalid Arhzaouy, a Scientist III at Beacon Therapeutics, has a strong background in gene therapy research. With experience at various prestigious institutions and companies, including AGTC and the University of Pennsylvania, Khalid's expertise lies in neurodevelopmental diseases and AAV gene therapy. Holding a PhD in Biochemistry from the University of Cologne, Khalid's career has been dedicated to advancing gene therapy technologies.
This person is not in any offices
Beacon Therapeutics
2 followers
Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.